Medicated Skin Care in France
Euromonitor International's Medicated Skin Care in France market report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.
Buy online to access strategic market analysis and an interactive statistical database of volume and value market sizes, company and brand shares, distribution and pricing data.
Tables: 58 | Publication date: Apr 2009
Why buy this report
- Get insight into trends in market performance
- Pinpoint growth sectors and identify factors driving change
- Identify market and brand leaders and understand the competitive environment
Product coverage
Acne treatments; Antiparasitics/lice (head and body) treatments; Antipruritics; Child-specific medicated skin care; Emollients/therapeutic moisturisers; Haemorrhoid treatments; Hair loss treatments; Lip care treatments; Medicated shampoos; Nappy (diaper) rash treatments; Topical allergy remedies/antihistamines; Topical antifungals; Topical germicidals/antiseptics; Vaginal antifungals
Table of contents
MEDICATED SKIN CARE IN FRANCE : MARKET INSIGHT
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 1 Sales of Medicated Skin Care by Subsector: Value 2003-2008
Table 2 Sales of Medicated Skin Care by Subsector: % Value Growth 2003-2008
Table 3 Herbal vs Standard Medicated Skin Care 2003-2008
Table 4 Acne Treatments by Format: % Value Breakdown 2004-2008
Table 5 Medicated Skin Care Company Shares by Value 2004-2008
Table 6 Medicated Skin Care Brand Shares by Value 2005-2008
Table 7 Acne Treatments Brand Shares by Value 2005-2008
Table 8 Hair Loss Treatments Brand Shares by Value 2005-2008
Table 9 Forecast Sales of Medicated Skin Care by Subsector: Value 2008-2013
Table 10 Forecast Sales of Medicated Skin Care by Subsector: % Value Growth 2008-2013
LOCAL COMPANY PROFILES - FRANCE
ARKOPHARMA SA, LABORATOIRES PHARMACEUTIQUES - OTC HEALTHCARE - FRANCE
STRATEGIC DIRECTION
KEY FACTS
Summary 1 Laboratoires Pharmaceutiques Arkopharma SA: Key Facts
Summary 2 Laboratoires Pharmaceutiques Arkopharma SA: Operational Indicators
COMPANY BACKGROUND
COMPETITIVE POSITIONING
Summary 3 Laboratoires Pharmaceutiques Arkopharma SA: Competitive Position 2008
BEAUFOUR-IPSEN SA - OTC HEALTHCARE - FRANCE
STRATEGIC DIRECTION
KEY FACTS
Summary 4 Beaufour-Ipsen SA: Key Facts
Summary 5 Beaufour-Ipsen SA: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
Summary 6 Beaufour-Ipsen SA: Production Statistics 2007
COMPETITIVE POSITIONING
Summary 7 Beaufour-Ipsen SA: Competitive Position 2008
COOPER SA - OTC HEALTHCARE - FRANCE
STRATEGIC DIRECTION
KEY FACTS
Summary 8 Cooper SA: Key Facts
Summary 9 Cooper SA: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
Summary 10 Cooper SA: Production Statistics 2007
COMPETITIVE POSITIONING
Summary 11 Cooper SA: Competitive Position 2008
GLAXOSMITHKLINE SANTé GRAND PUBLIC SAS - OTC HEALTHCARE - FRANCE
STRATEGIC DIRECTION
KEY FACTS
Summary 12 GlaxoSmithKline Santé Grand Public SAS: Key Facts
Summary 13 GlaxoSmithKline Santé Grand Public SAS: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
Summary 14 GlaxoSmithKline France: Production Statistics 2007
COMPETITIVE POSITIONING
Summary 15 GlaxoSmithKline Santé Grand Public SAS: Competitive Position 2008
JUVA SANTé, LABORATOIRES - OTC HEALTHCARE - FRANCE
STRATEGIC DIRECTION
KEY FACTS
Summary 16 Laboratoires Juva Santé: Key Facts
Summary 17 Laboratoires Juva Santé: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
Summary 18 Laboratoires Juva Santé: Production Statistics 2006
COMPETITIVE POSITIONING
Summary 19 Laboratoires Juva Santé: Competitive Position 2008
LABORATOIRES MCNEIL - OTC HEALTHCARE - FRANCE
STRATEGIC DIRECTION
KEY FACTS
Summary 20 Laboratoires McNeil: Key Facts
Summary 21 Laboratoires McNeil: Operational Indicators
COMPANY BACKGROUND
COMPETITIVE POSITIONING
Summary 22 Laboratoires McNeil: Competitive Position 2008
PIERRE FABRE SA, LABORATOIRES - OTC HEALTHCARE - FRANCE
STRATEGIC DIRECTION
KEY FACTS
Summary 23 Laboratoires Pierre Fabre SA: Key Facts
Summary 24 Laboratoires Pierre Fabre SA: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
Summary 25 Laboratoires Pierre Fabre SA: Production Statistics 2007
COMPETITIVE POSITIONING
Summary 26 Laboratoires Pierre Fabre SA: Competitive Position 2008
THéRAPLIX SA - OTC HEALTHCARE - FRANCE
STRATEGIC DIRECTION
KEY FACTS
Summary 27 Théraplix SA: Key Facts
COMPANY BACKGROUND
COMPETITIVE POSITIONING
Summary 28 Théraplix SA: Competitive Position 2008
UPSA, LABORATOIRES - OTC HEALTHCARE - FRANCE
STRATEGIC DIRECTION
KEY FACTS
Summary 29 Laboratoires UPSA: Key Facts
Summary 30 Laboratoires UPSA: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
Summary 31 UPSA Conseil SAS: Production Statistics 2007
COMPETITIVE POSITIONING
Summary 32 UPSA Conseil SAS: Competitive Position 2008
URGO, LABORATOIRES - OTC HEALTHCARE - FRANCE
STRATEGIC DIRECTION
KEY FACTS
Summary 33 Laboratoires Urgo: Key Facts
Summary 34 Laboratoires Urgo: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 35 Laboratoires Urgo: Competitive Position 2008
OTC HEALTHCARE IN FRANCE
EXECUTIVE SUMMARY
OTC healthcare suffers from consumers obtaining more prescription products
Increasing presence of self-service areas in chemists/pharmacies for OTC products
A fragmented market led by OTC manufacturers
Chemists/pharmacies remains the leading distribution channel
Positive performance through the development of self-medication
KEY TRENDS AND DEVELOPMENTS
The setting-up of self-service: its impact on self-medication
Vitamins and dietary supplements for everyone
The grey market is the new key target consumer group
Decreasing purchasing power favours Rx products
MARKET INDICATORS
Table 11 Consumer Expenditure on Health Goods and Medical Services 2003-2008
Table 12 Life Expectancy at Birth 2003-2008
MARKET DATA
Table 13 Sales of OTC Healthcare by Sector: Value 2003-2008
Table 14 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
Table 15 OTC Healthcare Company Shares by Value 2004-2008
Table 16 OTC Healthcare Brand Shares by Value 2005-2008
Table 17 Penetration of Private Label by Sector 2003-2008
Table 18 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008
Table 19 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008
Table 20 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013
Table 21 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013
APPENDIX
OTC Registration and Classification
Advertising
Packaging and Labelling
Distribution
Vitamins & Dietary Supplements Registration and Classification
EU Legislation
Self-medication and Preventative Medicine
Generics
Switches
Summary 36 Rx-to-OTC Healthcare Switches 2006-2008
DEFINITIONS
Summary 37 Research Sources